1. Sarcopenia in cirrhosis: From pathophysiology to interventional therapy
- Author
-
Huiling Chen, Chenyun Yang, Shijie Yan, Xintao Liu, Ligang Zhou, and Xinlu Yuan
- Subjects
Muscle mass ,Muscle function ,Survival ,End-stage liver disease ,Liver transplant ,Computed tomography ,Medicine ,Biology (General) ,QH301-705.5 - Abstract
Sarcopenia, characterized by the loss of skeletal muscle mass and function, is a significant complication in patients with cirrhosis. This condition not only exacerbates the overall morbidity and mortality associated with liver disease but also complicates patient management, increasing the risk of hospitalization, infections, and hepatic encephalopathy. Despite its clinical significance, sarcopenia in cirrhotic patients remains underdiagnosed and undertreated. This review aims to summarize current knowledge on the pathophysiology of sarcopenia in cirrhosis, including mechanisms such as altered metabolism, hormonal imbalances, and inflammation. Additionally, we explore diagnostic challenges and discuss emerging therapeutic strategies, including nutritional support, exercise, and pharmacological interventions. By highlighting the gaps in existing research and proposing directions for future studies, this review seeks to improve the management and outcomes of cirrhotic patients affected by sarcopenia.
- Published
- 2024
- Full Text
- View/download PDF